{
    "Variants Include": [
        {
            "Gene": "PARK2",
            "variants": [
                {
                    "HGVS": "NM_004562.3:c.1031A>G",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "A",
                        "alt": "G",
                        "position": "1031"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "G",
                        "position": "344"
                    },
                    "Description in input context": "E344G"
                },
                {
                    "HGVS": "NM_004562.3:c.824G>A",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "G",
                        "alt": "A",
                        "position": "824"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "Q",
                        "position": "275"
                    },
                    "Description in input context": "R275Q"
                },
                {
                    "HGVS": "NM_004562.3:c.761A>G",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "A",
                        "alt": "G",
                        "position": "761"
                    },
                    "Protein Change": {
                        "ref": "N",
                        "alt": "S",
                        "position": "254"
                    },
                    "Description in input context": "N254S"
                },
                {
                    "HGVS": "NM_004562.3:c.124C>T",
                    "cDNA Change": {
                        "transcript": "NM_004562.3",
                        "ref": "C",
                        "alt": "T",
                        "position": "124"
                    },
                    "Protein Change": {
                        "ref": "R",
                        "alt": "C",
                        "position": "42"
                    },
                    "Description in input context": "R42C"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "glioblastoma",
        "MONDO": "MONDO:0018177"
    },
    "Experiment Method": [
        {
            "Assay Method": "Protein blot",
            "Material used": {
                "Material Source": "Cell line",
                "Material Name": "T98G",
                "Description": "Protein blot showing expression of WT PARK2 and PARK2 with four cancer-specific mutations. Representative data for transfection into T98G are shown."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.1031A>G",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Expression of WT PARK2 and PARK2 with the E344G mutation in T98G cell line was shown."
                },
                {
                    "Variant": "NM_004562.3:c.824G>A",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Expression of WT PARK2 and PARK2 with the R275Q mutation in T98G cell line was shown."
                },
                {
                    "Variant": "NM_004562.3:c.761A>G",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Expression of WT PARK2 and PARK2 with the N254S mutation in T98G cell line was shown."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Expression of WT PARK2 and PARK2 with the R42C mutation in T98G cell line was shown."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT should be used as basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Colony formation assay",
            "Material used": {
                "Material Source": "Human cancer cell lines",
                "Material Name": "N.D.",
                "Description": "Tumor-derived mutations compromise the colony-forming ability of PARK2 in cancer cells. WT or mutant PARK2 was transfected into the cells indicated."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.1031A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced colony formation, but the E344G mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in colony-forming ability."
                },
                {
                    "Variant": "NM_004562.3:c.824G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced colony formation, but the R275Q mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in colony-forming ability."
                },
                {
                    "Variant": "NM_004562.3:c.761A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced colony formation, but the N254S mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in colony-forming ability."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced colony formation, but the R42C mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in colony-forming ability."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All assays performed in triplicate."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT should be used as basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "Empty vector should be used as basic negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "Student's t-test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "In vivo tumor growth assay",
            "Material used": {
                "Material Source": "DBTRG glioma cells",
                "Material Name": "DBTRG",
                "Description": "Reconstitution of PARK2 reduces growth rate in cancer cells. This experiment involved all specified variants (R42C, N254S, R275Q, E344G) and wild-type PARK2."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.1031A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced growth rate, but the E344G mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in reducing tumor growth rate in vivo."
                },
                {
                    "Variant": "NM_004562.3:c.824G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced growth rate, but the R275Q mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in reducing tumor growth rate in vivo."
                },
                {
                    "Variant": "NM_004562.3:c.761A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced growth rate, but the N254S mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in reducing tumor growth rate in vivo."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 significantly reduced growth rate, but the R42C mutant PARK2 showed performance consistent with empty vector, indicating complete loss-of-function in reducing tumor growth rate in vivo."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "All experiments were performed in duplicate."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT should be used as basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Empty vector should be used as basic negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": "N.D.",
            "Source": "N.D.",
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Ubiquitin Ligase Activity Assay",
            "Material used": {
                "Material Source": "Cancer cell lines",
                "Material Name": "N.D.",
                "Description": "Cancer-specific mutations in PARK2 substantially compromise the association of PARK2 with ubiquitinated target proteins in cancer cells."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.1031A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "The E344G mutation substantially compromised the association of PARK2 with ubiquitinated target proteins, leading to a substantial decrease in E3 ligase function."
                },
                {
                    "Variant": "NM_004562.3:c.824G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "The R275Q mutation substantially compromised the association of PARK2 with ubiquitinated target proteins, leading to a substantial decrease in E3 ligase function."
                },
                {
                    "Variant": "NM_004562.3:c.761A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "The N254S mutation substantially compromised the association of PARK2 with ubiquitinated target proteins, leading to a substantial decrease in E3 ligase function."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "The R42C mutation substantially compromised the association of PARK2 with ubiquitinated target proteins, leading to a substantial decrease in E3 ligase function."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT should be used as basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": "N.D.",
            "Source": "N.D.",
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cyclin E Ubiquitination and Degradation Assay",
            "Material used": {
                "Material Source": "Cancer cell lines",
                "Material Name": "N.D.",
                "Description": "WT PARK2 expression, but not mutant PARK2 expression, reduced Cyclin E levels."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.1031A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 expression, but not E344G mutant PARK2 expression, reduced Cyclin E levels, indicating complete loss-of-function for the mutant in this regard."
                },
                {
                    "Variant": "NM_004562.3:c.824G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 expression, but not R275Q mutant PARK2 expression, reduced Cyclin E levels, indicating complete loss-of-function for the mutant in this regard."
                },
                {
                    "Variant": "NM_004562.3:c.761A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 expression, but not N254S mutant PARK2 expression, reduced Cyclin E levels, indicating complete loss-of-function for the mutant in this regard."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "WT PARK2 expression, but not R42C mutant PARK2 expression, reduced Cyclin E levels, indicating complete loss-of-function for the mutant in this regard."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT should be used as basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": "N.D.",
            "Source": "N.D.",
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cell Cycle and Mitotic Instability Analysis",
            "Material used": {
                "Material Source": "Cancer cell lines",
                "Material Name": "N.D.",
                "Description": "PARK2 knockdown increased proportion of cells in S and G2-M phases, increased multipolar spindles, abnormal mitoses, and nuclear atypia."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_004562.3:c.1031A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PARK2 knockdown increased the proportion of cells in the S and G2-M phases, showed a significant increase in multipolar spindles and abnormal mitoses, and a marked increase in nuclear atypia, indicating impaired mitosis."
                },
                {
                    "Variant": "NM_004562.3:c.824G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PARK2 knockdown increased the proportion of cells in the S and G2-M phases, showed a significant increase in multipolar spindles and abnormal mitoses, and a marked increase in nuclear atypia, indicating impaired mitosis."
                },
                {
                    "Variant": "NM_004562.3:c.761A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PARK2 knockdown increased the proportion of cells in the S and G2-M phases, showed a significant increase in multipolar spindles and abnormal mitoses, and a marked increase in nuclear atypia, indicating impaired mitosis."
                },
                {
                    "Variant": "NM_004562.3:c.124C>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "complete loss-of-function",
                    "Result Description": "PARK2 knockdown increased the proportion of cells in the S and G2-M phases, showed a significant increase in multipolar spindles and abnormal mitoses, and a marked increase in nuclear atypia, indicating impaired mitosis."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT should be used as basic positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": "N.D.",
            "Source": "N.D.",
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}